🇨🇦 Pf-06804103 in Canada

Pf-06804103 (pf-06804103) regulatory status in Canada.

Marketing authorisation

Pf-06804103 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Pf-06804103 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Pf-06804103 in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.